Milestone closes first tranche of $55M series C

On Aug. 1, Milestone Pharmaceuticals Inc. (Montreal, Quebec) raised an undisclosed amount in the first tranche of a $55 million series C round led by new investor Novo Holdings A/S (Hellerup, Denmark). New investors Forbion Capital Partners and Tekla Capital Management also participated, as did existing investors Domain Associates, Fonds de solidarité FTQ, BDC Capital, Pappas Capital and GO Capital. The company expects a final close this year...